cas 1935936-86-9|| where to buy 2-(3-Cyclopropyl-6-oxopyridazin-1(6H)-yl)acetic acid

製品名:2-(3-Cyclopropyl-6-oxopyridazin-1(6H)-yl)acetic acid

IUPAC Name:2-(3-cyclopropyl-6-oxo-1,6-dihydropyridazin-1-yl)acetic acid

包装単位	有効在庫	価格（USD）
CM538118-100mg	in stock	ƓǊŉ
CM538118-250mg	in stock	ŉůƓ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1935936-86-9 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:1935936-86-9; 分子式:C9H10N2O3; 融点:-; SMILESコード:O=C(C=C1)N(CC(O)=O)N=C1C2CC2; 密度:

: Pyridazines; Pyridazine, also known as o-diazobenzene, is a six-membered heterocyclic compound containing two nitrogen heteroatoms in the 1 and 2 positions with a special structure and a wide biological activity. Pyridazine is more and more popular in drug development, and a variety of pyridazine drugs have been developed and marketed. From the perspective of the therapeutic field, pyridazine drug molecules are mainly used for tumor treatment, but also involve in many therapeutic fields such as inflammation, hypertension and cardiovascular disease. With the increase and in-depth of research, pyridazine drugs will play more roles in the treatment of diseases.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.